Lysosomes, often described as the recycling centers of the cell, perform essential roles in metabolic control by degrading damaged proteins and macromolecules into their basic constituents. Beyond this degradative role, lysosomes are instrumental in determining a cell’s fate — balancing growth signals with energy conservation pathways. Their dynamic positioning within the cell is integral to their function, yet the molecular details of how this spatial organization is regulated have remained elusive — until now.

At the core of this discovery is the GTPase protein ARL8B, which operates as a molecular switch to mobilize lysosomes along cellular microtubules toward the cell periphery. This migration enhances cellular growth and signaling activities. However, the mechanism by which ARL8B is inactivated, allowing lysosomes to reset to their basal state or respond to stress, had remained a mystery. The new findings reveal that TBC1D9B, a GAP (GTPase-activating protein), directly interacts with ARL8B to switch it off, thereby regulating lysosomal trafficking and function in response to cellular needs.

This regulatory process involves TBC1D9B binding to TMEM55B, a lysosomal membrane protein. The formation of this complex triggers the inactivation of ARL8B, effectively halting lysosomal movement and prompting their repositioning toward the cell center, especially during nutrient deprivation or metabolic stress. This repositioning facilitates autophagy — the cell’s self-cleaning process — intensifying the degradation and recycling of cellular components, which is vital for cell survival under adverse conditions.

Disruption of this finely tuned regulatory axis has profound implications. The researchers demonstrated that in cells lacking either TBC1D9B or TMEM55B, lysosomes become aberrantly distributed, dispersing across the cytoplasm rather than clustering in the perinuclear region. This mislocalization impairs autophagic flux, hindering the cell’s ability to respond to starvation and leading to metabolic imbalance. Such dysfunction is especially detrimental in neurons, where efficient proteostasis and cellular clearance are paramount to prevent accumulation of toxic protein aggregates.

The experimental approach combined advanced proteomics, genome editing tools such as CRISPR-Cas9, and confocal microscopy, enabling direct visualization and quantification of lysosome dynamics under varying genetic and environmental conditions. Using HeLa cell models with targeted knockout of TBC1D9B, the team visualized lysosomal markers (LAMP2) and tracked their redistribution in real-time. These high-resolution techniques uncovered the specific loss of spatial control over lysosomes in the absence of the TBC1D9B-mediated regulation of ARL8B.

Understanding this molecular pathway opens significant potential for medical intervention. Lysosomal dysfunction is implicated in a spectrum of human diseases, including neurodegenerative disorders like Alzheimer’s and Parkinson’s diseases, where defective clearance of aggregated proteins leads to neuronal death. Similarly, cancer cells exploit lysosomal systems to modulate their metabolism and survive in hostile microenvironments. Targeting the TBC1D9B-ARL8B axis could therefore provide novel strategies either to restore lysosomal function in degenerative diseases or to disrupt it in tumor cells, thereby limiting their growth.

Co-lead researchers Prof. Markus Damme and Prof. Volker Haucke emphasize the translational value of uncovering this regulatory module. By manipulating TBC1D9B activity or its interaction with TMEM55B, it may be possible to fine-tune lysosome positioning and function. This could bolster neuronal resilience against proteotoxic stress or potentiate immune responses by enhancing lysosome-mediated pathogen clearance, given immune cells’ reliance on ARL8B for trafficking and activation.

Moreover, the discovery underscores the significance of lysosome positioning, not merely their biochemical composition, in governing cellular metabolism. The spatial organization of lysosomes emerges as a critical determinant of their efficacy in responding to environmental cues and orchestrating intracellular signaling networks. This spatial regulation adds a new layer of complexity to lysosomal biology, expanding our understanding of how cellular organelles adapt and function.

The study’s authors used a multifaceted strategy to dissect this regulatory network, utilizing genetic ablation to pinpoint TBC1D9B’s role, and biochemical assays to characterize its GAP activity. Their proteomic analyses also identified TMEM55B as a vital scaffold protein facilitating the inactivation of ARL8B by TBC1D9B. The integration of these sophisticated approaches provides a comprehensive picture of lysosomal control mechanisms.

In light of these findings, future research directions may focus on developing small molecules or biologics that modulate TBC1D9B’s GAP activity or its interaction with TMEM55B. Such targeted therapies could represent a paradigm shift in treating diseases marked by lysosomal dysfunction. Additionally, further exploration of the ARL8B regulatory network may uncover additional proteins and pathways dictating lysosomal dynamics, offering a broader repertoire of therapeutic targets.

This pioneering work marks a significant advancement in cell biology, providing the missing piece in understanding how lysosomal function is intricately controlled at the molecular level. It highlights an elegant feedback system ensuring cellular adaptability and metabolic homeostasis, reinforcing lysosomes’ critical status as hubs of cellular health.

Subject of Research: Cells

Article Title: Control of lysosome function by the GTPase activating protein TBC1D9B and its binding partner TMEM55B.

News Publication Date: 14-Mar-2026

Web References: 10.1038/s41467-026-70345-y

Image Credits: Klaudia Kosieradzka, FMP, Berlin

Keywords: Lysosomes, ARL8B, TBC1D9B, TMEM55B, GTPase-activating protein, autophagy, cellular metabolism, neurodegenerative diseases, cancer, lysosomal trafficking, proteostasis, molecular biology

Cell division is one of the most fundamental biological events, requiring the accurate and faithful duplication of DNA so that each daughter cell inherits an intact genetic blueprint. This DNA replication process is managed by specialized molecular complexes that move along the DNA strands rapidly and with high precision. Meanwhile, the transcription machinery traverses the same DNA strands to decode genetic information into RNA, which then guides protein synthesis. Importantly, these two complexes operate on the very same DNA template, creating inevitable risks of collision.

KCTD10’s role is critical because DNA replication machinery progresses at a faster rate than transcription machinery, raising the potential for harmful encounters that can induce DNA breaks or genomic instability—a hallmark of cancerous cells. Prior to this discovery, biologists had little insight into how cells detect and resolve such conflicts efficiently to preserve genomic integrity during cell division.

The Mayo Clinic research team discovered that KCTD10 functions as a sensor that detects imminent collisions between the replication and transcription machines on DNA. Upon sensing trouble, KCTD10 activates an enzyme called CUL3, which executes a targeted ubiquitination process. This process selectively tags proteins that impede the swift passage of the replication machinery, marking them for removal. By clearing the transcription machinery ahead, KCTD10 prevents DNA damage, allowing replication to proceed smoothly.

Ubiquitination, in this context, operates as a molecular signaling mechanism that orchestrates the controlled degradation or repositioning of proteins obstructing the DNA replication pathway. The interplay between KCTD10 and CUL3 exemplifies a sophisticated cellular defense strategy to maintain genome integrity by ensuring precise coordination between replication and transcription activities.

Interestingly, the research highlights that the co-directional orientation of replication and transcription machinery—which run in the same direction on DNA—may not be a random evolutionary artifact but rather an organizational strategy shaped by the functions of proteins like KCTD10. This implies a broader significance of KCTD10 in structuring the human genome’s architecture to minimize conflict-induced DNA damage.

Beyond its fundamental biological importance, KCTD10’s activity—or lack thereof—has profound implications for cancer biology. Absence or malfunction of KCTD10 has been linked to genomic instability, fostering mutations that promote tumorigenesis. Additionally, clinical observations have associated developmental delays with KCTD10 deficiency, underscoring its vital role beyond cancer.

Remarkably, the very vulnerability caused by the loss of KCTD10 in cancer cells could be exploited for therapeutic interventions. Cancer cells deficient in this protective mechanism become particularly susceptible to DNA damage and stress, presenting a unique “Achilles’ heel” that targeted treatments could attack selectively, sparing healthy cells.

This insight offers a new therapeutic window to develop cancer treatments that push vulnerable tumor cells beyond their capacity to cope with DNA damage, tipping them towards programmed cell death. Identifying cancers deficient in KCTD10 expression and understanding the molecular pathways affected provide a strategic focus for drug development.

Jake Kloeber, a dual M.D.-Ph.D. student and co-lead author of the study, emphasizes that decoding these underlying molecular processes in normal and cancerous cells could revolutionize precision oncology. His work exemplifies the synergy between clinical medicine and biomedical research, aiming to translate molecular discoveries into impactful cancer therapies.

The Mayo Clinic has embedded this research within its larger Precure initiative, an ambitious program seeking to create predictive and interceptive tools capable of diagnosing and managing diseases at their earliest, most manageable phases. The study’s outcomes are expected to contribute valuable biomarkers and therapeutic targets as part of this vision.

The detailed mechanistic insights into how KCTD10 senses transcription-replication conflicts and mediates genome protection deepen our molecular grasp of cell division fidelity. These findings highlight the complexity and elegance of intracellular coordination essential for life and reinforce the importance of tightly regulated protein networks in genomic maintenance.

As research on KCTD10 continues, efforts will focus on elucidating the prevalence of KCTD10 deficiency across various cancer types and screening for drugs—either novel compounds or existing agents—that can selectively eradicate cancer cells exhibiting this weakness. This promising path may lead to breakthroughs in personalized cancer therapy, optimizing treatment efficacy and minimizing side effects.

In summary, Mayo Clinic’s identification of KCTD10 as a guardian protein coordinating DNA replication and transcription machinery offers profound insights into maintaining genome stability. It heralds a new frontier for cancer research where understanding molecular traffic control at the DNA level can be harnessed to devise innovative, targeted therapeutic strategies.

Subject of Research: The molecular mechanisms by which KCTD10 protein senses and resolves co-directional transcription-replication conflicts to maintain genomic integrity and its implications for cancer therapy.

Article Title: KCTD10 is a sensor for co-directional transcription–replication conflicts

News Publication Date: October 8, 2025

Web References:

• Study published in Nature: https://www.nature.com/articles/s41586-025-09585-9
• Mayo Clinic: https://www.mayoclinic.org/

References:
Lou, Z., Kloeber, J., et al. “KCTD10 is a sensor for co-directional transcription–replication conflicts.” Nature, 8 Oct 2025.

Keywords:
KCTD10, DNA replication, transcription, genomic stability, cancer therapy, ubiquitination, CUL3, genome integrity, co-directional conflicts, molecular traffic controller, protein sensor, tumorigenesis.

Every day, our bodies engage in a remarkable process of cellular division, where billions of cells are replaced to ensure we maintain proper physiological functions. This intricate process is guided by our genetic blueprint, which is composed of over three billion base pairs of DNA. However, during cell division, challenges arise when the cellular mechanisms responsible for copying this genetic material encounter what is known as “replication stress.” This stress can lead to errors in DNA duplication, resulting in mutations that contribute to diseases such as cancer.

One significant source of replication stress is the formation of alternative DNA structures. These structures can act as physical impediments to the duplication process, causing delays or complete stalls. Among these unique formations are G-quadruplexes, also known as G4s, which are formed in regions of the genome rich in guanine. These compact structures present a considerable challenge for the DNA copying machinery, setting the stage for potential advancements in cancer therapeutics.

Recent research conducted at the Memorial Sloan Kettering Cancer Center utilized advanced cryo-electron microscopy technology to delve into the complexities of G-quadruplexes. A team of structural and molecular biologists aimed to illuminate the behavior of these structures in the context of DNA replication, recognizing their emerging role as a therapeutic target in oncology. Their groundbreaking findings provide insight into the mechanisms that underpin cellular replication and its relationship with G4s, enhancing our understanding of both cancer biology and fundamental aspects of human genetics.

The findings, published in the prestigious journal Science, have thrust G-quadruplexes into the spotlight as key players in replicative stress. By employing state-of-the-art cryo-electron microscopy, the researchers were able to observe these structures in real-time, marking the first occasion where the intricate interactions between G4s and the cellular replication machinery were captured with precision. In their study, they unveiled a detailed representation of how the protein complexes responsible for DNA replication, called replisomes, navigate around these obstacles during the replication process.

In their investigations, the team highlighted the evolutionary versatility of DNA. While the iconic double helix may be the most recognized structure, DNA can take on various forms under different physiological conditions. G-quadruplexes are increasingly recognized for their potential to disrupt key cancer-promoting genes, such as MYC and KRAS. As such, they pose a unique opportunity for therapeutic intervention aimed at hindering cancer cell proliferation by targeting these specific structures.

Dr. Sahil Batra and Dr. Dirk Remus, co-leads of the study, spotlight the importance of understanding the molecular dynamics surrounding G4s. They emphasize that while several drugs are currently in development to specifically target G-quadruplexes in cancer treatments, a deeper understanding of how these structures impact DNA replication is essential. The researchers illustrate that during the cellular division process, G-quadruplexes can become entangled within the DNA unwinding machinery, akin to obstacles on a railway track. Such entrapment can significantly interfere with the timely completion of DNA replication, further complicating cellular division.

Moreover, the study sheds light on an unexpected discovery regarding the motion of the CMG helicase, a crucial protein complex that plays a central role in DNA unwinding. In their findings, the researchers noted that instead of the conventional model of enzyme movement, the CMG helicase exhibits a unique "helical inchworm" motion. By adopting a helical configuration, this enzyme can effectively navigate along DNA strands, which facilitates the unwinding process necessary for replication. This innovative mechanism stands to redefine our comprehension of protein movement along DNA in complex organisms, challenging existing paradigms drawn from simpler biological models.

The implications of these discoveries extend far beyond mere academic curiosity. Strikingly detailed knowledge of G-quadruplex behavior and helicase dynamics presents exciting avenues for therapeutic development. By understanding how these structures impede replication, scientists can explore novel strategies to enhance cancer treatment efficacy. Inhibition of G4 formation within cancer cells could effectively stall their division, rendering them less aggressive and more susceptible to traditional treatment modalities.

As key stakeholders in the quest against cancer, the researchers highlight how the identification of G-quadruplexes as significant contributors to genomic instability can inform broader cancer research strategies. Given the established connections between G4 formations, oncogenesis, and extended telomere maintenance, the study offers a clearer picture of potential genomic vulnerabilities that could be exploited for clinical benefit.

Dr. Batra emphasizes the necessity of continued research aimed at unraveling the complexities surrounding DNA replication and repair, particularly concerning G4 structures. By deciphering how cells navigate the challenges posed by G-quadruplexes, researchers open doors for enhanced comprehension of cancer biology and its accompanying intricacies.

As the scientific community continues to analyze the significance of these findings, the quest to unveil the mysteries of DNA replication remains a driving force in modern molecular biology. Each new discovery regarding G-quadruplexes and their interactions with cellular mechanisms not only enriches our fundamental understanding of biology but also lays the groundwork for future therapeutic innovations that could transform cancer treatment paradigms.

Through a collaborative effort that spans across multiple disciplines, the researchers have established a foundational framework for future inquiries into DNA replication dynamics. Their work emphasizes an integrated approach where insights into molecular behavior can significantly influence therapeutic strategies. In the ever-evolving landscape of cancer research, G-quadruplexes have now emerged as not just mere anomalies but pivotal components worthy of dedicated exploration.

Subject of Research: G-quadruplexes in DNA replication and their implications for cancer treatment.
Article Title: G-quadruplex–stalled eukaryotic replisome structure reveals helical inchworm DNA translocation.
News Publication Date: 7-Mar-2025
Web References: Science Publication
References: None available.
Image Credits: Hite and Remus Labs, Memorial Sloan Kettering Cancer Center.
Keywords: DNA replication, cryo-electron microscopy, cancer research, G-quadruplexes, molecular dynamics.